BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11092546)

  • 1. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA; Fiorini MT; Abell C; Williams DH
    Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium.
    Cooper MA; Williams DH
    Chem Biol; 1999 Dec; 6(12):891-9. PubMed ID: 10631517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
    Rao J; Yan L; Lahiri J; Whitesides GM; Weis RM; Warren HS
    Chem Biol; 1999 Jun; 6(6):353-9. PubMed ID: 10375541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity adsorbents for the vancomycin group of antibiotics.
    Yan H; Zhao Q; Yuan J; Cheng X; He B
    Biotechnol Appl Biochem; 2000 Feb; 31(1):15-20. PubMed ID: 10669398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative binding interactions of glycopeptide antibiotics.
    Shiozawa H; Chia BC; Davies NL; Zerella R; Williams DH
    J Am Chem Soc; 2002 Apr; 124(15):3914-9. PubMed ID: 11942828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms.
    Beauregard DA; Maguire AJ; Williams DH; Reynolds PE
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2418-23. PubMed ID: 9371343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurements of vancomycin binding to self-assembled peptide monolayers on chips by quartz crystal microbalance.
    Tseng MC; Chang YP; Chu YH
    Anal Biochem; 2007 Dec; 371(1):1-9. PubMed ID: 17919449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
    Allen NE; LeTourneau DL; Hobbs JN
    Antimicrob Agents Chemother; 1997 Jan; 41(1):66-71. PubMed ID: 8980756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
    Lessard IA; Healy VL; Park IS; Walsh CT
    Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.
    Yang Z; Vorpagel ER; Laskin J
    J Am Chem Soc; 2008 Oct; 130(39):13013-22. PubMed ID: 18774809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.
    Entress RM; Dancer RJ; O'Brien DP; Try AC; Cooper MA; Williams DH
    Chem Biol; 1998 Jun; 5(6):329-37. PubMed ID: 9653551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
    Nitanai Y; Kikuchi T; Kakoi K; Hanamaki S; Fujisawa I; Aoki K
    J Mol Biol; 2009 Feb; 385(5):1422-32. PubMed ID: 18976660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin dimer formation between analogues of bacterial peptidoglycan surfaces probed by force spectroscopy.
    Batchelor M; Zhou D; Cooper MA; Abell C; Rayment T
    Org Biomol Chem; 2010 Mar; 8(5):1142-8. PubMed ID: 20165806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via Its Bivalent Motifs of Interaction.
    Bowden S; Joseph C; Tang S; Cannon J; Francis E; Zhou M; Baker JR; Choi SK
    Biochemistry; 2018 May; 57(18):2723-2732. PubMed ID: 29651842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of high-affinity peptide ligands for vancomycin.
    Yao N; Wu CY; Xiao W; Lam KS
    Biopolymers; 2008; 90(3):421-32. PubMed ID: 18260149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
    Jain RK; Trias J; Ellman JA
    J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
    Axelsen PH; Li D
    Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
    McComas CC; Crowley BM; Boger DL
    J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.